The Tylenol Shakedown: When Your President Runs a Protection Racket from the Oval Office

White House Autism Claims Spark Scientific and Market BacklashThe initial source is an excerpt from a legal presentation by Charles “Chip” Babcock and Jamila M. Brinson, both of Jackson Walker LLP, discussing defamation and business disparagement damages with detailed sections on the elements of a defamation claim and the various types of damages available in such actions. The remaining sources address a contemporary controversy where President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. publicly announced a potential link between Tylenol use during pregnancy and autism, a claim that medical and scientific experts heavily dispute. These latter sources highlight the immediate fallout for Kenvue Inc., the maker of Tylenol, which faces a "nightmare of potential litigation" and is actively defending its product, noting that decades of research have found no proven causal link between acetaminophen and autism. The legal context provided by the first source on defamation and the media coverage of the disputed public health claims in the subsequent sources create a strong contrast between the academic discussion of legal recourse and the real-world implications of public accusations.